Facial Nerve Enhancement on Gadolinium-DTPA in a Case with Neurosarcoidosis

Internal Medicine

Volumn 36, Issue 11, 1997, Pages 825-828

  Sugita, Manabu ^a   Sano, Motoki ^a   Uchigata, Masanobu ^a   Aruga, Toru ^a   Matsuoka, Rokuro ^a  

^a Showa General Hospital   (Japan)

Author keywords

Angiotensin converting enzyme (ACE); Facial nerve palsy; Hydrocephalus; Magnetic resonance imaging (MRI)

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE; GADOLINIUM PENTETATE; GLUCOCORTICOID; PREDNISOLONE;

ADULT; ARTICLE; BRAIN VENTRICLE PERITONEUM SHUNT; CASE REPORT; CEREBROSPINAL FLUID; FACIAL NERVE; FACIAL NERVE DISEASE; FACIAL NERVE PARALYSIS; FOLLOW UP; HUMAN; HYDROCEPHALUS; IMAGE ENHANCEMENT; MALE; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; SARCOIDOSIS;

ADULT; CONTRAST MEDIA; FACIAL NERVE; FACIAL NERVE DISEASES; FACIAL PARALYSIS; FOLLOW-UP STUDIES; GADOLINIUM DTPA; GLUCOCORTICOIDS; HUMANS; HYDROCEPHALUS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MALE; PEPTIDYL-DIPEPTIDASE A; PREDNISOLONE; SARCOIDOSIS; VENTRICULOPERITONEAL SHUNT;

EID: 0031279341     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.36.825     Document Type: Article

References (22)

1. Colover J. Sarcoidosis with involvement of the nervous system. Brain 71: 451, 1948.
2. Delaney P. Neurologic manifestations in sarcoidosis. Ann Intern Med 87: 336, 1977.
3. Stern BJ, Krumholz A, Johns C, Scott P, Nissim J. Sarcoidosis and its neurological manifestations. Arch Neurol 42: 909, 1985.
4. Sharma OP, Sharma AM. Sarcoidosis of the nervous system. A clinical approach. Arch Intern Med 151: 1317, 1991.
5. Graham E, James DG. Neurosarcoidosis. Sarcoidosis 5: 125, 1988.
6. Matthews WB. Sarcoidosis of the nervous system. J Neurol Neurosurg Psychiatry 28: 23, 1965.
7. Scott TF. Neurosarcoidosis: progress and clinical aspects. Neurology 43: 8, 1993.
8. Silverstein A, Feuyer M, Siltzbach LE, et al. Neurological Sarcoidosis. Arch Neurol 12: 1, 1965.
9. Hayes WS, Sherman JL, Stern BJ, Citrin CM, Pulaski PD. MR and CT evaluation of intracranial sarcoidosis. AJR Am J Roentgenol 149: 1043, 1987.
10. Carmody RF, Mafee MF, Goodwin JA, Small K, Haery C. Orbital and optic pathway sarcoidosis: MR findings. AJNR Am J Neuroradiol 15: 775, 1994.
11. Murphy TP. MRI of the facial nerve during paralysis. Otolaryngol Head Neck Surg 104: 47, 1991.
12. Fulbright RK, Erdum E, Sze G, Byrne T. Cranial nerve enhancement in the Guillain-Barré syndrome. AJNR Am J Neuroradiol 16: 923, 1995.
13. Sherman JL, Stern BJ. Sarcoidosis of the CNS: comparison of unenhanced and enhanced MR images. AJNR Am J Neuroradiol 11: 915, 1990.
14. Lexa FJ, Grossman RI. MR of sarcoidosis in the head and spine: spectrum of manifestations and radiographic response to steroid therapy. AJNR Am J Neuroradiol 15: 973, 1994.
15. Lukin RR, Chambers AA, Soleimanpour M. Outlet obstruction of the fourth ventricle in sarcoidosis. Neuroradiology 10: 65, 1975.
16. Strefling AM, Summerville JW, Urich H. Involvement of choroid plexuses in neurosarcoidosis. Acta Neuropathol (Berl) 74: 402, 1987.
17. Spencer N, Ross G, Helm G, Madison J, Urich H. Aqueductal obstruction in sarcoidosis. Clin Neuropathol 8: 158, 1989.
18. Chan Seem CP, Norfolk G, Spokes EG. CSF angiotensin-converting enzyme in neurosarcoidosis [letter]. Lancet 1: 456, 1985.
19. Oksanen V, Fyhrquist F, Somer H, Grönhagen-Riska C. Angiotensin converting enzyme in cerebrospinal fluid: a new assay. Neurology 35: 1220, 1985.
20. Oksanen V, Grönhagen-Riska C, Fyhrquist F, Somer H. Systemic manifestations and enzyme studies in sarcoidosis with neurologic involvement. Acta Med Scand 218: 123, 1985.
21. Jones DB, Mitchell D, Horn DB, Edwards CRW. Cerebrospinal fluid angiotensin converting enzyme levels in the diagnosis of neurosarcoidosis. Scott Med J 36: 144, 1991.
22. Chapelon C, Ziza JM, Piette JC, et al. Neurosarcoidosis: signs, course and treatment in 35 confirmed cases. Medicine (Baltimore) 69: 261, 1990.